Maturitas
Volume 56, Issue 3 , Pages 263-272 , 20 March 2007

A prospective analysis of alcohol consumption and onset of perimenopause

  • Ghasi S. Phillips

      Affiliations

    • Harvard School of Public Health, Epidemiology, Kresge Building, 9th Floor, 677 Huntington Avenue, Boston, MA 02115, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 347 267 4558.
  • ,
  • Lauren A. Wise

      Affiliations

    • Slone Epidemiology Center, Boston University, 1010 Commonwealth Avenue, Boston, MA 02215, United States
  • ,
  • Bernard L. Harlow

      Affiliations

    • Epidemiology and Community Health, University of Minnesota School of Public Health, 1300 South Second Street, Suite 300, Minneapolis, MN 55454, United States

Received 7 March 2006 ,Revised 22 August 2006 ,Accepted 25 August 2006.

References 

  1. World Health Organization Scientific Group. Research on the menopause. Geneva: World Health Organization; 1981;
  2. Kritz-Silverstein D, Barrett-Connor E. Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health. 1993;83(7):983–988
  3. Snowdon DA, Kane RL, Beeson WL, et al. Is early natural menopause a biologic marker of health and aging?. Am J Public Health. 1989;79(6):709–714
  4. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347(9003):714–718
  5. Medina D. Mammary developmental fate and breast cancer risk. Endocr Relat Cancer. 2005;12(3):483–495
  6. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;14(2):103–115
  7. Brett KM, Cooper GS. Associations with menopause and menopausal transition in a nationally representative US sample. Maturitas. 2003;45(2):89–97
  8. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145(2):124–133
  9. Hardy R, Kuh D, Wadsworth M. Smoking, body mass index, socioeconomic status and the menopausal transition in a British national cohort. Int J Epidemiol. 2000;29(5):845–851
  10. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18(1):199–206
  11. Torgerson DJ, Avenell A, Russell IT, Reid DM. Factors associated with onset of menopause in women aged 45–49. Maturitas. 1994;19(2):83–92
  12. Cooper GS, Baird DD, Darden FR. Measures of menopausal status in relation to demographic, reproductive, and behavioral characteristics in a population-based study of women aged 35–49 years. Am J Epidemiol. 2001;153(12):1159–1165
  13. Hardy R, Kuh D. Reproductive characteristics and the age at inception of the perimenopause in a British National Cohort. Am J Epidemiol. 1999;149(7):612–620
  14. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of moods and cycles. Arch Gen Psychiatry. 2003;60(1):29–36
  15. Wise LA, Krieger N, Zierler S, Harlow BL. Lifetime socioeconomic position in relation to onset of perimenopause. J Epidemiol Community Health. 2002;56(11):851–860
  16. Cramer DW, Harlow BL, Xu H, Fraer C, Barbieri R. Cross-sectional and case-controlled analyses of the association between smoking and early menopause. Maturitas. 1995;22(2):79–87
  17. Kinney A, Kline J, Levin B. Alcohol, caffeine and smoking in relation to age at menopause. Maturitas. 2005;
  18. Reichman ME, Judd JT, Longcope C, et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993;85(9):722–727
  19. Sarkola T, Makisalo H, Fukunaga T, Eriksson CJ. Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women. Alcohol Clin Exp Res. 1999;23(6):976–982
  20. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 1997;94(25):14138–14143
  21. Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol. 1999;179(3):297–304
  22. Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol. 1998;12(4):865–869
  23. Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry. 1983;140(1):41–46
  24. Harlow BL, Cohen LS, Otto MW, Liberman RF, Spiegelman D, Cramer DW. Demographic, family, and occupational characteristics associated with major depression: the Harvard study of moods and cycles. Acta Psychiatr Scand. 2002;105(3):209–217
  25. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard study of moods and cycles. Arch Gen Psychiatry. 1999;56(5):418–424
  26. Willett WC. Nutritional epidemiology. 2nd ed.. New York, NY: Oxford University Press; 1998;
  27. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;279(7):535–540
  28. Giovannucci E, Colditz G, Stampfer MJ, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991;133(8):810–817
  29. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316(19):1174–1180
  30. Avis NE, McKinlay SM. The Massachusetts Women's Health Study: an epidemiologic investigation of the menopause. J Am Med Womens Assoc. 1995;50(2):45–4963
  31. Brambilla DJ, McKinlay SM. A prospective study of factors affecting age at menopause. J Clin Epidemiol. 1989;42(11):1031–1039
  32. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol. 1994;140(12):1091–1095
  33. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause. 2000;7(5):334–349
  34. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854:1–452.
  35. Institute Inc SAS. SAS/STAT user's guide. 9.1. Cary, NC: SAS Institute Inc.; 2003;
  36. Cox D. Regression models and life tables (with discussion). JR Stat Soc (B). 1972;34:187–220
  37. Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta Med. 2003;69(7):589–599
  38. Fremont L. Biological effects of resveratrol. Life Sci. 2000;66(8):663–673
  39. Langcake P, Pryce RJ. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection and injury. Physiol Plant Pathol. 1976;9:77–86
  40. Lamuela-Raventos RM, Romero-Perez AI, Waterhouse AL, De La Torre-Boronat MC. Direct HPLC analysis of cis and trans-resveratrol and piceid isomers in Spanish red Vitis vinifera wines. J Agric Food Chem. 1995;43:281–283
  41. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001;61(20):7456–7463
  42. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 1999;59(11):2596–2601
  43. Pervaiz S. Resveratrol—from the bottle to the bedside?. Leuk Lymphoma. 2001;40(5–6):491–498
  44. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology. 2000;141(10):3657–3667
  45. Calabrese G. Nonalcoholic compounds of wine: the phytoestrogen resveratrol and moderate red wine consumption during menopause. Drugs Exp Clin Res. 1999;25(2–3):111–114
  46. Byers M, Kuiper GG, Gustafsson JA, Park-Sarge OK. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol Endocrinol. 1997;11(2):172–182
  47. Saunders PT, Millar MR, Williams K, et al. Differential expression of estrogen receptor-alpha and -beta and androgen receptor in the ovaries of marmosets and humans. Biol Reprod. 2000;63(4):1098–1105

PII: S0378-5122(06)00312-4

doi: 10.1016/j.maturitas.2006.08.008

Maturitas
Volume 56, Issue 3 , Pages 263-272 , 20 March 2007